Clinical Trials Browser

Phase 2 × INDUSTRY × BO-112 × Clear all

NCT06422936 2026-01-26

SPOTLIGHT204

Phase 2 Active not recruiting

Carcinoma, Basal Cell

NCT04570332 2025-11-26

SPOTLIGHT203

Phase 2 Completed

42 enrolled 12 charts

Melanoma

NCT04508140 2024-11-29

Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver Metastasis

Phase 2 Terminated

18 enrolled 13 charts

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms